Skip to main content
H.R. 1683 118th Congress House

Generic Animal Drug Advancement Act

Official title: To amend the Federal Food, Drug, and Cosmetic Act to make certain changes with respect to the approval of abbreviated applications for the approval of new animal drugs, and for other purposes.

Introduced: March 21, 2023 Introduced by: Nancy Mace Republican · South Carolina See on congress.gov
Health
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 31, 2023
Referred to the Subcommittee on Health.
Mar 21, 2023
Introduced in House
Mar 21, 2023
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 31, 2023

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Generic Animal Drug Advancement Act

This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 7

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 7 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1683: Generic Animal Drug Advancement Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-1683/
MLA
"H.R. 1683: Generic Animal Drug Advancement Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-1683/.
Bluebook (legal)
H.R. 1683, 118th Cong. (2026), https://openamerica.io/bill/118-HR-1683/.
Markdown link
[H.R. 1683: Generic Animal Drug Advancement Act](https://openamerica.io/bill/118-HR-1683/)
Report a problem